Search results
Moderna Stock Seesaws After The FDA Throws It A Curveball
Investor's Business Daily· 6 days agoThe FDA was due to make a decision by May 12. Moderna emphasized the FDA has not said it found any...
Is This a Setback for Moderna?
The Motley Fool via AOL· 2 days agoIt's also important to keep in mind that the RSV market size is $10 billion, meaning there's room for all three players to carve out market share and...
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Investor's Business Daily· 2 days agoOne analyst called the results "transformational." And Moderna stock surged more than 9% on Dec. 19,...
Wealthspire Advisors LLC Has $301,000 Stock Position in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 4 days agoWealthspire Advisors LLC trimmed its stake in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 7.9% in the fourth quarter, according to its most recent disclosure with the Securities ...
Moderna and OpenAI Are Teaming Up, but Does That Make the Stock a Buy?
Motley Fool via Yahoo Finance· 4 days agoAnd, at a time when its coronavirus vaccine revenue is no longer enough to make the stock as...
Moderna Announces Update on Investigational RSV Vaccine
Digital Journal· 6 days agoView the original press release on accesswire.com ACCESSWIRE News network reaching more than 1,500 media outlets in 98 countries. The newest, fastest-growing and most disruptive ...
Moderna's RSV Vaccine Approval Faces Setback as FDA Delays Decision
Homenewshere.com· 6 days agoModerna announced that the FDA had delayed approval of its RSV vaccine to the end of May due to...
FDA delays decision on Moderna RSV vaccine
BioPharma Dive via Yahoo Finance· 6 days agoThe regulator cited “administrative constraints,” rather than any issue with Moderna’s trial data, for missing a May 12 deadline, the company said.
Moderna says FDA will not complete review of RSV vaccine by May 12 deadline
Market Watch· 6 days agoModerna Inc.’s stock fell 2.6% Friday, after the company said the Food and Drug Administration will...
Moderna says FDA delaying decision on RSV vaccine approval, shares fall
Investing.com· 6 days agoModerna says FDA delaying decision on RSV vaccine approval, shares fall
